Atlas Trials

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Clinical trial NCT06047457 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06047457
Sponsor
Ipsen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Episodic Migraine
Start date
2023-09-29
Primary completion
2026-06-01
Enrollment
751

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.